Site map


  • Home
  • About us
  • Overview
  • How we work
  • Our strategy
  • Our people
  • The Antisoma Board
  • The Senior Management Team
  • Corporate Governance
  • Contact us
  • Products
  • Pipeline
  • AS1413 (amonafide L-malate, formerly Xanafide®)
  • AS1411
  • ASA404
  • Investor centre
  • Company highlights
  • Share price
  • Share price table
  • Share price chart
  • Share price calculator
  • Share price download
  • Financial reports
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • Calendar and events
  • Regulatory announcements
  • Shareholder information
  • Shareholder meetings
  • 20% disapplication
  • ADR program
  • Analysts and advisors
  • Corporate Governance
  • Media centre
  • Webcasts
  • ATTRACT-1 phase III trial of ASA404 halted
  • Press releases
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • Notes to editors
  • Deutsche version
  • Version française
  • Partnering
  • Partnering conferences
  • Current collaborations
  • Careers
  • Current vacancies